Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
0 hedge funds and large institutions have $0 invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 27 closing their positions.
100% less funds holding
Funds holding: 27 → 0 (-27)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1.65M → $0 (-$1.65M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 27
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$924K |
| 2 |
JC
JBF Capital
Aspen,
Colorado
|
-$141K |
| 3 |
Renaissance Technologies
New York
|
-$108K |
| 4 |
SR
Summer Road
West Palm Beach,
Florida
|
-$97K |
| 5 |
Two Sigma Advisers
New York
|
-$90K |
CORV Hedge Fund Activity: Q2 2020 in Review
0 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q2 2020, worth a combined $0 — down 100% from $1.65M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of CORV and 0 opened new positions — a net loss of 27 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Beryl Capital Management, exiting entirely with an estimated $924K sold.
- 0 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q2 2020, down from 27 in Q1 2020.
- Funds reported $0 of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q2 2020, down 100% quarter-over-quarter.
- 0 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q2 2020 and 27 closed out, a net change of -27 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q2 2020 was Beryl Capital Management, an estimated $924K sold.
Based on aggregated 13F filings for Q2 2020.